Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity

Journal of Neuroscience Research

Volumn 58, Issue 3, 1999, Pages 417-425

  Mook Jung, Inhee ^a,b   Shin, Ji Eun ^a,b   Yun, Hwan Sung ^a   Huh, Kyoon ^a   Koh, Jae Young ^b   Park, Hyung Keun ^c   Jew, Sang Sup ^c   Jung, Min Whan ^a  

^a Ajou University School of Medicine   (South Korea)

^b University of Ulsan   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Alzheimer's disease; Apoptosis; Asiaticoside; Free radical; LTP

Indexed keywords

AMYLOID BETA PROTEIN; ASIATIC ACID; ASIATICOSIDE; FREE RADICAL; HYDROGEN PEROXIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; STAUROSPORINE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; FACILITATION; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; CELL DEATH; CELL LINE; ELECTRIC STIMULATION; EXCITATORY AMINO ACID ANTAGONISTS; FREE RADICALS; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; MOLECULAR STRUCTURE; NEURONS; NEUROTOXINS; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; STAUROSPORINE; STRUCTURE-ACTIVITY RELATIONSHIP; SYNAPTIC TRANSMISSION; TRITERPENES;

EID: 0033231331     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19991101)58:3<417::AID-JNR7>3.0.CO;2-G     Document Type: Article

References (31)

1. Ancolio K, Marambaud P, Dauch P, Checler F. 1997. α-secretase-derived product of β-amyloid precursor protein is decresed by presenilin 1 mutations linked to familial Alzheimer's disease. J Neurochem 69:2494-2499.
2. Behl C, Davis JB, Lesley R, Schubert D. 1994. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77:817-827.
3. Beyreuther K, Pollwein P, Multhaup G, Monning U, Konig G, Dyrks T, Schubert W, Masters CL. 1993. Regulation and expression of the Alzheimer's beta/A4 amyloid protein precursor in health, disease, and Down's syndrome. Ann NY Acad Sci 695:91-102.
4. Butterfield DA, Hensley K, Harris M, Mattson M, Carney J. 1994. Beta amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications of Alzheimer's disease. Biochm Biophys Res Commun 200:710-715.
5. De Souza ND, Shah V, Desai PD, Inamdar PK, D'Sa A, Ammonamanchi R, Dohadwalla AN, Lakdawala AD, Mandrekar SS, Blumbach J. 1990. 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use. European Patent 0 383 171 A2.
6. Duff K, Eckman C, Zehr C, Yu X, Prada CM, Perez-tur J, Hutton M, Buee L, Harigaya Y, Yager D, Morgan D, Gordon MN, Holcomb L, Refolo L, Zenk B, Hardy J, Younkin S. 1996. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383:710-713.
7. Frucht SJ, Koo EH. 1994. Beta amyloid protein is higher in Alzheimer's disease brains: description of a quantitative biochemical assay. J Neuropath Exp Neurol 52:640-647.
8. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blockwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J. 1995. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527.
9. Gravina SA, Ho L, Eckman CB, Long KE, Otvos L, Younkin LH, Suzuki N, Younkin SG. 1995. Amyloid beta protein(Aβ) in Alzheimer's disease brain; biochemical and immunocytochemical analysis with antibodies specific for forms ending at Aβ40 or Aβ42(43). J Biol Chem 270:7013-7016.
10. Guilian D, Haverkamp LJ, Yu J, Karshin W, Torn D, Li J, Kazanskaia A, Kirkpatrick J, Rocher AE. 1998. The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J Biol Chem 273:29719-29726.
11. Haass C, Schlossmacher MG, Hung AY, Vigo PC, Mellon A, Ostaszewski BL, Lieburg I, Koo EH, Shenk D, Teplow DB, Selkoe DJ. 1992. Amyloid beta peptide is produced by cultured cell during normal metabolism. Nature 359:322-325.
12. Hardy J. 1997. Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci 20:154-159.
13. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274:99-102.
14. Hyman BT, Tanzi RE. 1992. Amyloid, dementia, and Alzheimer's disease. Curr Op Neurol. Neurosurg 5:88-93.
15. Kowall NW, Beal MF, Busciglio J, Duffy LK, Yankner BA. 1991. An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. Proc Natl Acad Sci. USA 88:7247-7251.
16. Lamere CA, Lopera F, Kosik KS, Lendon CL, Saido TC, Yamaguchi H, Ruiz A, Martinez A, Madrigal L, Hincapie L, Arango LJC., Koo EH, Goate AM, Selkoe DJ, Arango VJC. 1996. The E280A presenilin 1 mutation leads to distinct Alzheimer's disease phenotype: increased amyloid-β42 deposition and severe cerebellar pathology. Nature Med 2:1146-1150.
17. Lannfelt L, Bogdanovic N, Appelgren H, Axelman K, Lilius L, Hansson G, Schenk D, Hardy J, Winblad B. 1994. Amyloid precursor protein mutation causes Alzheimer's disease in a Swedish family. Neurosci Lett 168:254-256.
18. Larson J, Wong D, Lynch G. 1986. Patterned stimulation at the theta frequency is optimal for induction of hippocampal long-term potentiation. Brain Res 368:347-350.
19. Li YP, Bushnell AF, Lee CM, Perlmutter LS, Wong SK. 1996. Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 738:196-204.
20. Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. 1993. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955.
21. Mark RJ, Pang Z, Geddes JW, Uchida K, Mattson MP. 1997. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J Neurosci 17:1046-1054.
22. O'Banion MK, Finch CE. 1996. Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease. Neurobiol Aging 17:669-671.
23. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW. 1993. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
24. Pike CJ, Ramezan-Arab N, Cotman CW. 1997. β-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants. J Neurochem 69:1601-1611.
25. Pointel JP, Boccalon H, Cloarec M, Ledevehat C, Joubert M. 1987. Titrated extract of Centella asiatica(TECA) in the treatment of venous insufficiency of the lower limbs. Angiology 38:46-50.
26. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird TD, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Vitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lanfelt L, Selkoe DJ, Younkin SG. 1996. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and presenilin 2 and APP mutations linked to familial Alzheimer's disease. Nature Med 2:864-870.
27. Selkoe DJ. 1991. The molecular pathology of Alzheimer's disease. Neuron 6:487-498.
28. Shoji M, Golde TE, Ghiso J, Cheung TT, Estus S, Shaffer LM, Cai X-D, Mckay DM, Tintner R, Frangione B, Younkin S. 1992. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258:126-129.
29. Thinakaran G, Slunt HH, Sisodia SS. 1995. Novel regulation of chondroitin sulfate glucosaminoglycan modification of APP and its homologue APLP2. J Biol Chem 270:16522-16525.
30. Wroblewski F, LaDue JS. 1955. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 90:210-213.
31. Yamazaki T, Ihara Y. 1998. Effects of specific protease inhibitors on amyloid β-protein 42 secretion. Neurobiol Aging 19:S77-79.